text: Stock Update (NYSE:FIT): Fitbit Inc Adds New Relationships with New York Life, Pitney Bowes, SAP, Sharp Healthcare and Others
  Corey Williams- December 21, 2016, 11:45 AM EDT
  Fitbit Inc (NYSE:FIT) announced the addition of new customers including New York Life, Pitney Bowes, SAP, Sharp Healthcare and partners that will offer Fitbit activity trackers and programs to employees across a variety of industries. Fitbit continues to build corporate wellness programs that prioritize increasing employee engagement, improving health outcomes and lowering healthcare costs.
  Fitbit Group Health corporate wellness offering includes access to Fitbit's suite of award winning trackers, custom e-commerce storefronts, seamless distribution, engaging wellness challenges and comprehensive tracking and reporting. (Original Source)
  Shares of Fitbit are currently trading at $7.47, up $0.03 or +0.40%. FIT has a 1-year high of $30.96 and a 1-year low of $7.40. The stock's 50-day moving average is $8.62 and its 200-day moving average is $12.79.
  On the ratings front, Fitbit has been the subject of a number of recent research reports. In a report issued on December 8, Deutsche Bank analyst Sherri Scribner downgraded FIT to Hold, with a price target of $9, which represents a potential upside of 21% from where the stock is currently trading. Separately, on December 7, Mizuho's Betty Chen reiterated a Hold rating on the stock and has a price target of $9.
  According to TipRanks.com, which ranks over 7,500 financial analysts and bloggers to gauge the performance of their past recommendations, Sherri Scribner and Betty Chen have a yearly average return of 13.1% and a loss of -4.8% respectively. Scribner has a success rate of 68% and is ranked #227 out of 4291 analysts, while Chen has a success rate of 42% and is ranked #3879.
  Sentiment on the street is mostly neutral on FIT stock. Out of 20 analysts who cover the stock, 16 suggest a Hold rating , 2 suggest a Sell and 2 recommend to Buy the stock. The 12-month average price target assigned to the stock is $10.20, which implies an upside of 37% from current levels.